pLX304 Luciferase-V5 blast Citations (3)
Originally described in: Tumor-Suppressor Inactivation of GDF11 Occurs by Precursor Sequestration in Triple-Negative Breast Cancer.Bajikar SS, Wang CC, Borten MA, Pereira EJ, Atkins KA, Janes KA Dev Cell. 2017 Nov 20;43(4):418-435.e13. doi: 10.1016/j.devcel.2017.10.027. PubMed Journal
Articles Citing pLX304 Luciferase-V5 blast
Articles |
---|
Tousled-like kinase 2 targets ASF1 histone chaperones through client mimicry. Simon B, Lou HJ, Huet-Calderwood C, Shi G, Boggon TJ, Turk BE, Calderwood DA. Nat Commun. 2022 Feb 8;13(1):749. doi: 10.1038/s41467-022-28427-0. PubMed |
A bi-steric mTORC1-selective inhibitor overcomes drug resistance in breast cancer. Meng D, Zhao X, Yang YC, Navickas A, Helland C, Goodarzi H, Singh M, Bandyopadhyay S. Oncogene. 2023 Jul;42(28):2207-2217. doi: 10.1038/s41388-023-02737-z. Epub 2023 Jun 1. PubMed |
Role of Nudt2 in Anchorage-Independent Growth and Cell Migration of Human Melanoma. Hidmi S, Nechushtan H, Razin E, Tshori S. Int J Mol Sci. 2023 Jun 22;24(13):10513. doi: 10.3390/ijms241310513. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.